title: Teratogenic effects of vaginal boric acid treatment during pregnancy.
authors.affiliation: Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, and Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary.
authors.forename: N
authors.initials: N
authors.lastname: Acs
authors.forename: F
authors.initials: F
authors.lastname: Bánhidy
authors.forename: E
authors.initials: E
authors.lastname: Puhó
authors.forename: A E
authors.initials: AE
authors.lastname: Czeizel
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000145:classification / Q000209:etiology*; D001888:Boric Acids / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D001888:Boric Acids